Cooper Companies soars after initiating strategic review

Medical device maker Cooper Companies' COO.O shares jump 13% to $87 premarket

Co says it is initiating a formal strategic review aimed at identifying opportunities to enhance long-term shareholder value

Co says it is actively focused on improving performance in core markets, expanding market share, enhancing operational efficiency and generating strong returns through capital deployment initiatives as part of the review

Co forecasts fiscal 2026 revenue of $4.299 bln to $4.338 bln vs analysts' estimate of $4.32 bln

"It's encouraging to see organic growth guidance starting at a level that gives the company more room to maneuver, and adding total shareholder return to the executive performance rubric is also a solid step in the right direction for the strategic review" - J.P.Morgan

11 of 20 brokerages rate the stock "buy" or higher, eight "hold" and one "sell" or lower; their median PT is $85.5, as per data compiled by LSEG

YTD, stock fell 16.2% through Thursday